Martin Ottolini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Martin Ottolini has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Kathleen B. Madden
Departments of Pediatrics and Academic Affairs, The Uniformed Services University of the Health Sciences, Bethesda, USA
2 shared publicationsMichael Rajnik
Departments of Pediatrics and Academic Affairs, The Uniformed Services University of the Health Sciences, Bethesda, USA
2 shared publicationsBlake Cirks
Departments of Pediatrics and Academic Affairs, The Uniformed Services University of the Health Sciences, Bethesda, USA
1 shared publicationBlake T. Cirks
Department of Pediatrics, Division of Pediatric Infectious Diseases, Walter Reed National Military Medical Center, Bethesda, USA
1 shared publicationChristina Schofield
Madigan Army Medical Center, Tacoma, WA, United States
1 shared publicationDeepika Mor
Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, MD, United States
1 shared publication
Latest Publications
- Open Access
- 9 December 2021
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 23 (12) , 1-12
Pediatric Infectious Diseases Encountered During Wartime—Part 1: Experiences and Lessons Learned From Armed Conflict in the Modern Era
Purpose of Review Armed conflicts occur globally, with some regions experiencing heightened instability for many years. A better understanding of the infectious disease impact on children in armed conflict will allow aid organizations to anticipate and mitigate the most serious problems. Recent Findings Armed conflicts are estimated to have caused approximately 30 million civilian deaths during the past 27 years, with two-thirds occurring in women and children. Children are extremely vulnerable to the mass population displacements, experiencing a combined loss of safety, nutrition, shelter, hygiene, and health care. Under these circumstances, the emergence and prevalence of multiple infectious diseases can result in heightened morbidity and mortality long after active conflict ceases. Summary Factors leading to increased infectious diseases in populations in crisis due to armed conflict and lessons learned from recent outbreaks are discussed in detail. Acute respiratory infections, diphtheria, measles, varicella, and cholera are a few of the more common infectious diseases that take advantage of populations displaced or disrupted by conflict. Key issues include the ability of countries or non-governmental organizations (NGOs) to keep up with basic childhood immunizations, and how rapidly disease outbreaks are recognized and addressed with disease-specific interventions.
- 9 December 2021
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 23 (12) , 1-12
Open AccessPediatric Infectious Diseases Encountered During Wartime—Part 1: Experiences and Lessons Learned From Armed Conflict in the Modern Era
Purpose of Review Armed conflicts occur globally, with some regions experiencing heightened instability for many years. A better understanding of the infectious disease impact on children in armed conflict will allow aid organizations to anticipate and mitigate the most serious problems. Recent Findings Armed conflicts are estimated to have caused approximately 30 million civilian deaths during the past 27 years, with two-thirds occurring in women and children. Children are extremely vulnerable to the mass population displacements, experiencing a combined loss of safety, nutrition, shelter, hygiene, and health care. Under these circumstances, the emergence and prevalence of multiple infectious diseases can result in heightened morbidity and mortality long after active conflict ceases. Summary Factors leading to increased infectious diseases in populations in crisis due to armed conflict and lessons learned from recent outbreaks are discussed in detail. Acute respiratory infections, diphtheria, measles, varicella, and cholera are a few of the more common infectious diseases that take advantage of populations displaced or disrupted by conflict. Key issues include the ability of countries or non-governmental organizations (NGOs) to keep up with basic childhood immunizations, and how rapidly disease outbreaks are recognized and addressed with disease-specific interventions.
- 29 November 2021
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 23 (12) , 1-11
Pediatric Infectious Diseases Encountered During Wartime Part II: Infectious Diseases Complications in the Individual Pediatric Patient
- 29 November 2021
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 23 (12) , 1-11
Pediatric Infectious Diseases Encountered During Wartime Part II: Infectious Diseases Complications in the Individual Pediatric Patient
- 1 March 2021
- Published by Elsevier in Academic Pediatrics
- Vol. 21 (2) , 252-258
Pediatric Hospitalists’ Performance and Perceptions of Script Concordance Testing for Self-Assessment
- 1 March 2021
- Published by Elsevier in Academic Pediatrics
- Vol. 21 (2) , 252-258
Pediatric Hospitalists’ Performance and Perceptions of Script Concordance Testing for Self-Assessment
- Open Access
- 24 March 2015
- Published by Elsevier in Journal of Clinical Virology
- Vol. 67, 17-22
Neuraminidase inhibitor therapy in a military population
- 24 March 2015
- Published by Elsevier in Journal of Clinical Virology
- Vol. 67, 17-22
Open AccessNeuraminidase inhibitor therapy in a military population
- 1 February 1995
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 171 (2) , 440-443
Systemic Immunoprophylaxis of Nasal Respiratory Syncytial Virus Infection in Cotton Rats
The cotton rat model was used to test whether systemically administered immunoglobulin could protect nasal tissues against low challenge doses of respiratory syncytial virus (RSV). Animals were pretreated by intraperitoneal injection of human immunoglobulin with moderate (1:2226) or high (1:15,000) neutralizing antibody titers to RSV (day 0), challenged intranasally with RSV Long at doses ranging from 101 to 105 pfu (day 1), and sacrificed for virus titration (day 5). Pretreatment with moderate-titer immunoglobulin effected complete or near complete nasal protection against low to moderate (101 -103 pfu) RSV challenge doses and a significant reduction in nasal RSV titers at high (104 -105 pfu) challenge doses. Pretreatment with high-titer immunoglobulin effected near complete nasal protection at an RSV challenge dose of 103 pfu and highly significant and significant reductions in nasal RSV titers at challenge doses of 104 and 105 pfu, respectively. Immunoprophylaxis effected complete or near complete pulmonary protection at all RSV challenge doses.
- 1 February 1995
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 171 (2) , 440-443
Systemic Immunoprophylaxis of Nasal Respiratory Syncytial Virus Infection in Cotton Rats
The cotton rat model was used to test whether systemically administered immunoglobulin could protect nasal tissues against low challenge doses of respiratory syncytial virus (RSV). Animals were pretreated by intraperitoneal injection of human immunoglobulin with moderate (1:2226) or high (1:15,000) neutralizing antibody titers to RSV (day 0), challenged intranasally with RSV Long at doses ranging from 101 to 105 pfu (day 1), and sacrificed for virus titration (day 5). Pretreatment with moderate-titer immunoglobulin effected complete or near complete nasal protection against low to moderate (101 -103 pfu) RSV challenge doses and a significant reduction in nasal RSV titers at high (104 -105 pfu) challenge doses. Pretreatment with high-titer immunoglobulin effected near complete nasal protection at an RSV challenge dose of 103 pfu and highly significant and significant reductions in nasal RSV titers at challenge doses of 104 and 105 pfu, respectively. Immunoprophylaxis effected complete or near complete pulmonary protection at all RSV challenge doses.